作者
J Alexandre Ribeiro, Diana Cunha‐Reis, Luisa V Lopes, Joana E Coelho, Ana Rita Costenla, Paulo Correia‐de‐Sá, Rodrigo A Cunha, Alexandre de Mendonça, Ana M Sebastião
发表日期
2001/1/1
期刊
Drug development research
卷号
52
期号
1‐2
页码范围
337-345
出版商
John Wiley & Sons, Inc.
简介
Adenosine receptors are involved in interactions with receptors for other neurotransmitters and/or neuromodulators. This opens novel possibilities for the action of this nucleoside. Either through direct receptor–receptor modulation or beyond the receptor level (PKA, PKC, or calcium channels), it appears that to protect the cells from insult adenosine moves around to use as many several receptor systems as possible, namely, receptors for neuropeptides (CGRP and VIP), ionotropic (NMDA) and metabotropic (mGlur I and III) glutamate receptors, GABA, and nicotinic autofacilitatory, muscarinic, and dopamine receptors. With these, adenosine might synchronize or desynchronize synaptic transmission in order to fine‐tune the nervous system. Drug Dev. Res. 52:337–345, 2001. © 2001 Wiley‐Liss, Inc.
引用总数
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024111211131
学术搜索中的文章
JA Ribeiro, D Cunha‐Reis, LV Lopes, JE Coelho… - Drug development research, 2001